Laboratorios Farmaceuticos Rovi, S.A. Share Price
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.40 EUR | -0.17% |
|
-3.12% | -9.61% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 2.94B 3.36B 2.7B 2.51B 4.77B 320B 4.85B 32.46B 12.58B 157B 12.62B 12.34B 541B | P/E 2026 * |
21.9x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.91B 3.33B 2.67B 2.49B 4.72B 317B 4.8B 32.15B 12.46B 155B 12.5B 12.22B 535B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 3.17x |
| Free-Float |
31.63% | Yield 2026 * |
1.7% | Yield 2027 * | 1.95% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -0.17% | ||
| 1 week | -3.12% | ||
| Current month | -0.78% | ||
| 1 month | -0.78% | ||
| 3 months | -30.55% | ||
| 6 months | -9.39% | ||
| Current year | -9.61% |
| 1 week | 57.2 |  | 58.95 |
| 1 month | 57.2 | | 59.7 |
| Current year | 57.2 | | 86.7 |
| 1 year | 51.65 | | 86.7 |
| 3 years | 37.96 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 26/07/2007 | |
| Director of Finance/CFO | - | 31/12/2000 | |
| Chief Tech/Sci/R&D Officer | - | 31/12/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 26/07/2007 | |
| Director/Board Member | - | 26/07/2007 | |
| Chairman | - | 16/07/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/06/23 | Buy | Director | 1,000 | 0.0019% | ||
| 12/04/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 14/03/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | -3.12% | +2.96% | +35.57% | 3.35B | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,063B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 611B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 444B | |
| -1.20% | -1.94% | +26.41% | +20.22% | 324B | |
| +4.94% | +3.39% | +39.92% | +28.93% | 285B | |
| +2.42% | +1.60% | +30.06% | +42.24% | 283B | |
| +2.47% | +5.18% | -24.80% | -39.60% | 219B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 195B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 156B | |
| Average | +2.09% | +3.53% | +28.00% | +53.77% | 358.4B | |
| Weighted average by Cap. | +1.85% | +5.07% | +41.51% | +80.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 886M 711M 663M 1.26B 84.33B 1.28B 8.56B 3.32B 41.36B 3.33B 3.25B 143B | 898M 1.03B 825M 769M 1.46B 97.86B 1.48B 9.93B 3.85B 48B 3.86B 3.78B 165B |
| Net income | 133M 152M 122M 114M 216M 14.49B 220M 1.47B 570M 7.11B 571M 559M 24.49B | 178M 203M 163M 152M 288M 19.35B 293M 1.96B 761M 9.49B 763M 747M 32.7B |
| Net Debt | -27.87M -31.9M -25.59M -23.87M -45.25M -3.04B -46.01M -308M -119M -1.49B -120M -117M -5.13B | -85.9M -98.3M -78.88M -73.56M -139M -9.36B -142M -950M -368M -4.59B -369M -361M -15.82B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | €57.40 | -0.17% | 107,292 |
| 01/07/26 | €57.50 | -0.61% | 74,835 |
| 30/06/26 | €57.85 | -1.45% | 129,596 |
| 29/06/26 | €58.70 | +0.17% | 107,694 |
| 26/06/26 | €58.60 | -1.10% | 84,479 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
